BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 67 filers reported holding BOLT BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $5,482,000 | -40.3% | 3,703,991 | -17.8% | 0.26% | -42.3% |
Q2 2022 | $9,188,000 | -25.5% | 4,503,991 | 0.0% | 0.45% | -30.6% |
Q1 2022 | $12,341,000 | -44.1% | 4,503,991 | 0.0% | 0.65% | -37.7% |
Q4 2021 | $22,070,000 | -61.3% | 4,503,991 | 0.0% | 1.04% | -64.5% |
Q3 2021 | $56,975,000 | -18.2% | 4,503,991 | 0.0% | 2.95% | -4.6% |
Q2 2021 | $69,632,000 | -53.0% | 4,503,991 | 0.0% | 3.09% | -49.5% |
Q1 2021 | $148,226,000 | – | 4,503,991 | – | 6.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $5,183,000 | 2.45% |
Nan Fung Group Holdings Ltd | 1,166,952 | $3,197,000 | 1.52% |
Vivo Capital, LLC | 3,871,291 | $10,607,000 | 0.73% |
Samsara BioCapital, LLC | 1,049,153 | $2,875,000 | 0.72% |
Novo Holdings A/S | 4,503,991 | $12,341,000 | 0.65% |
Sofinnova Investments, Inc. | 2,754,437 | $7,547,000 | 0.57% |
Hawkeye Capital Management, LLC | 415,039 | $1,137,000 | 0.45% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,230,250 | $6,111,000 | 0.19% |
Board of Trustees of The Leland Stanford Junior University | 719,546 | $1,972,000 | 0.11% |
Echo Street Capital Management LLC | 123,804 | $5,493,000 | 0.04% |